BDS
EW icon

Banco de Sabadell’s Edwards Lifesciences EW Stock Holding History

Banco de Sabadell’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-32,522
Closed -$2.56M – 346
2020
Q3 		$2.56M Buy
+32,522
New +$2.54M 0.29% 83
2019
Q4 		– Sell
-21,684
Closed -$1.59M – 330
2019
Q3 		$1.59M Buy
+21,684
New +$1.52M 0.22% 105

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Banco de Sabadell's EW Position: Q4 2020 in Review

Banco de Sabadell sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 32,522 shares — an estimated $2.56M sold.

Banco de Sabadell first reported a position in EW in Q3 2019 and held it in 2 quarters. The position peaked at $2.56M in Q3 2020. 1,158 funds tracked by Wall St. Rank hold EW as of Q4 2020.

  • Banco de Sabadell reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
  • Banco de Sabadell sold 32,522 Edwards Lifesciences shares in Q4 2020, an estimated $2.56M.
  • Banco de Sabadell first reported a position in Edwards Lifesciences in Q3 2019 and held it in 2 quarters.
  • Banco de Sabadell's Edwards Lifesciences position peaked at $2.56M in Q3 2020.
  • 1,158 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on Banco de Sabadell's 13F filing for Q4 2020, filed 12 Feb 2021.